<DOC>
	<DOC>NCT01356004</DOC>
	<brief_summary>Immunotherapy was reported in the treatment of psoriasis. Treatment of resistant psoriasis may be difficult and cyclosporine can induce some remission. The investigators hypothesized that the combined use of live attenuated varicella vaccine as an adjuvant therapy to low dose cyclosporine in the treatment of severe resistant psoriasis can give positive responses.</brief_summary>
	<brief_title>Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Severe psoriasis: At least 30% of body involved) according to the rule of nine. Resistance to conventional therapy (PUVA, methotrexate, retinoids): (Maximum PASI 50% improvement while on treatment for a duration not less than 6 months). Immunologically competent individuals with Seropositive for the varicella antibodies Any contraindication to live attenuated varicella vaccine Any contraindication to cyclosporine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>severe resistant</keyword>
</DOC>